ZMYM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.605570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.236600E-01
Normal-vs-Stage2
1.961560E-01
Normal-vs-Stage3
1.199380E-01
Normal-vs-Stage4
7.389600E-01
Stage1-vs-Stage2
6.449400E-01
Stage1-vs-Stage3
1.848470E-02
Stage1-vs-Stage4
7.561400E-01
Stage2-vs-Stage3
8.678400E-02
Stage2-vs-Stage4
4.612800E-01
Stage3-vs-Stage4
1.187780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.496210E-01
Normal-vs-AfricanAmerican
6.895400E-01
Normal-vs-Asian
2.375600E-01
Caucasian-vs-AfricanAmerican
3.611400E-01
Caucasian-vs-Asian
7.934600E-01
AfricanAmerican-vs-Asian
4.513400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.191780E-01
Normal-vs-Female
2.440400E-01
Male-vs-Female
4.023600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.737400E-01
Normal-vs-Age(41-60Yrs)
4.431400E-01
Normal-vs-Age(61-80Yrs)
1.005400E-01
Normal-vs-Age(81-100Yrs)
8.381800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.811400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.172800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.607600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.900200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.773900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.905600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.003960E-01
Normal-vs-Daily Drinker
2.432800E-01
Normal-vs-Weekly Drinker
1.213400E-01
Normal-vs-Occasional Drinker
4.267400E-01
Normal-vs-Social Drinker
5.352600E-01
Non Drinker-vs-Daily Drinker
7.176400E-01
Non Drinker-vs-Weekly Drinker
9.728400E-01
Non Drinker-vs-Occasional Drinker
6.422000E-02
Non Drinker-vs-Social Drinker
4.741800E-02
Daily Drinker-vs-Weekly Drinker
7.896000E-01
Daily Drinker-vs-Occasional Drinker
2.317200E-01
Daily Drinker-vs-Social Drinker
1.850040E-01
Weekly Drinker-vs-Occasional Drinker
1.056000E-01
Weekly Drinker-vs-Social Drinker
7.985700E-02
Occasional Drinker-vs-Social Drinker
7.924800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.599780E-01
Normal-vs-Grade 2
2.349900E-02
Normal-vs-Grade 3
4.241500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.132200E-02
Grade 1-vs-Grade 3
2.939900E-02
Grade 1-vs-Grade 4
1.599780E-01
Grade 2-vs-Grade 3
6.575200E-01
Grade 2-vs-Grade 4
2.349900E-02
Grade 3-vs-Grade 4
4.241500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.862000E-01
Normal-vs-NonDiabetic
1.729360E-01
Diabetic-vs-NonDiabetic
1.566630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.401400E-01
Normal-vs-NoPancreatitis
1.162820E-01
Pancreatitis-vs-NoPancreatitis
4.417400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.621810E-01
Normal-vs-N1
1.828180E-01
N0-vs-N1
4.923000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.270000E-01
Normal-vs-TP53-NonMutant
3.554800E-01
TP53-Mutant-vs-TP53-NonMutant
3.178000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
